ClinicalTrials.Veeva

Menu

Topical Instillation of Tranexamic Aacid in Bronchoscopy to Decrease Bleeding During Entobronchial & Transbronchial Biopsiy: a Prospective Double Blind Placebo Controlled Study

L

Liran Levy

Status and phase

Unknown
Phase 2

Conditions

Bronchoscopy Biopsy

Treatments

Drug: saline
Drug: tranexamic acid

Study type

Interventional

Funder types

Other

Identifiers

NCT02219152
0321-14

Details and patient eligibility

About

Bleeding during transbronchial ro endobronchial biopsy is rather a common complication.

Mostly this is an insignificant bleeding, but in 3% of the biopsies there is a substantial amount of bleeding that requires a special treatment or follow up.

The goal of this study is to examine whether submission of tranexamic acid during the biopsy could diminish the amount of bleeding.

Enrollment

120 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient that are candidates to endobronchial or transcronchial biopsy

Exclusion criteria

  • S/P MI or CVA or PE or DVT .
  • S/P thrombophilia.
  • Patients under coagulation therpay
  • Chronic Renal Failure
  • Pregnancy

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

120 participants in 2 patient groups, including a placebo group

tranexamic acid
Experimental group
Description:
tranexamic acid will be administrated using the bronchoscope
Treatment:
Drug: tranexamic acid
saline
Placebo Comparator group
Description:
the saline will be administrated using an infusion during the biopsy.
Treatment:
Drug: saline

Trial contacts and locations

1

Loading...

Central trial contact

Liran Levy, MD; Liran Levy, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems